Special Edition | US tax reform: Considerations for health care and life sciences execs
Life Sciences & Health Care
January 24 | 1 p.m. ET | 18:00 GMT
Host: David Green, partner, Deloitte Tax LLP
1 Overview CPE credit | Taxes
In the first major tax reform legislation since the 1980s, what provisions impact life sciences and health care organizations, what do business executives need to understand and plan for now, and how could tax reform affect your business strategy? We’ll discuss:
- Opportunities that a lower corporate tax rate could create in biopharma and medtech.
- How the elimination of the ACA individual mandate penalty might impact health plans.
- Implications of the legislation for not-for-profit hospitals and providers.
Participants will learn how the new tax law is likely to affect business and strategy decisions for life sciences and health executives in 2018 and beyond.